This is an RSS newsfeed from BioMed Central It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit http://www.biomedcentral.com/info/about/rss/ Current Opinion in Molecular Therapeutics - Latest articles http://thomsoncurrentdrugs.com/products/journals/comt The latest articles from Current Opinion in Molecular Therapeutics (ISSN 1464-8431) published by Current Drugs Limited. IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection http://www.biomedcentral.com/1464-8431/10/407 T Jones Current Opinion in Molecular Therapeutics 2008, 10:407-417 2008-07-30 doi:10.1186/cd-929751 Current Opinion in Molecular Therapeutics 1464-8431 10 407 2008-07-30 Golimumab, a fully human monoclonal antibody against TNFalpha http://www.biomedcentral.com/1464-8431/10/393 G Hutas Current Opinion in Molecular Therapeutics 2008, 10:393-406 2008-07-30 doi:10.1186/cd-929750 Current Opinion in Molecular Therapeutics 1464-8431 10 393 2008-07-30 Oncolytic vaccinia virus: From bedside to benchtop and back http://www.biomedcentral.com/1464-8431/10/387 SH Thorne Current Opinion in Molecular Therapeutics 2008, 10:387-392 2008-07-30 doi:10.1186/cd-929748 Current Opinion in Molecular Therapeutics 1464-8431 10 387 2008-07-30 The utility of cells as vehicles for oncolytic virus therapies http://www.biomedcentral.com/1464-8431/10/380 SJ Russell and KW Peng Current Opinion in Molecular Therapeutics 2008, 10:380-386 2008-07-30 doi:10.1186/cd-929747 Current Opinion in Molecular Therapeutics 1464-8431 10 380 2008-07-30 Virus combinations and chemotherapy for the treatment of human cancers http://www.biomedcentral.com/1464-8431/10/371 S Kumar, L Gao, B Yeagy and T Reid Current Opinion in Molecular Therapeutics 2008, 10:371-379 2008-07-30 doi:10.1186/cd-929745 Current Opinion in Molecular Therapeutics 1464-8431 10 371 2008-07-30 Exploiting synergies between radiation and oncolytic viruses http://www.biomedcentral.com/1464-8431/10/362 KJ Harrington, A Melcher, G Vassaux, HS Pandha and RG Vile Current Opinion in Molecular Therapeutics 2008, 10:362-370 2008-07-30 doi:10.1186/cd-929744 Current Opinion in Molecular Therapeutics 1464-8431 10 362 2008-07-30 Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy http://www.biomedcentral.com/1464-8431/10/356 C-O Yun Current Opinion in Molecular Therapeutics 2008, 10:356-361 2008-07-30 doi:10.1186/cd-929741 Current Opinion in Molecular Therapeutics 1464-8431 10 356 2008-07-30 Exploiting diversity: Genetic approaches to creating highly potent and efficacious oncolytic viruses http://www.biomedcentral.com/1464-8431/10/350 M Bauzon and TW Hermiston Current Opinion in Molecular Therapeutics 2008, 10:350-355 2008-07-30 doi:10.1186/cd-929739 Current Opinion in Molecular Therapeutics 1464-8431 10 350 2008-07-30 Recent progress in allogeneic stem cell transplantation http://www.biomedcentral.com/1464-8431/10/343 J Mattsson Current Opinion in Molecular Therapeutics 2008, 10:343-349 2008-07-30 doi:10.1186/cd-929738 Current Opinion in Molecular Therapeutics 1464-8431 10 343 2008-07-30 Stem-cell based therapies for brain tumors http://www.biomedcentral.com/1464-8431/10/334 S Yip and K Shah Current Opinion in Molecular Therapeutics 2008, 10:334-342 2008-07-30 doi:10.1186/cd-929734 Current Opinion in Molecular Therapeutics 1464-8431 10 334 2008-07-30 Cancer stem cell targeted agents: Therapeutic approaches and consequences http://www.biomedcentral.com/1464-8431/10/323 S Chumsri and AM Burger Current Opinion in Molecular Therapeutics 2008, 10:323-333 2008-07-30 doi:10.1186/cd-929733 Current Opinion in Molecular Therapeutics 1464-8431 10 323 2008-07-30 Cellular carriers or free viruses? http://www.biomedcentral.com/1464-8431/10/321 LW Seymour, R Cawood and KD Fisher Current Opinion in Molecular Therapeutics 2008, 10:321-322 2008-07-30 doi:10.1186/cd-929731 Current Opinion in Molecular Therapeutics 1464-8431 10 321 2008-07-30 Web alert http://www.biomedcentral.com/1464-8431/10/319 AC Stephens Current Opinion in Molecular Therapeutics 2008, 10:319-320 2008-07-30 doi:10.1186/cd-929730 Current Opinion in Molecular Therapeutics 1464-8431 10 319 2008-07-30 Patent alert http://www.biomedcentral.com/1464-8431/10/315 Reuters Current Awareness Analysts Thomson Current Opinion in Molecular Therapeutics 2008, 10:315-318 2008-07-30 doi:10.1186/cd-929728 Current Opinion in Molecular Therapeutics 1464-8431 10 315 2008-07-30 Paper alert http://www.biomedcentral.com/1464-8431/10/311 RE Hurst and S Antoniu Current Opinion in Molecular Therapeutics 2008, 10:311-314 2008-07-30 doi:10.1186/cd-929725 Current Opinion in Molecular Therapeutics 1464-8431 10 311 2008-07-30 Ofatumumab, a human monoclonal antibody for lymphoid malignancies and autoimmune disorders http://www.biomedcentral.com/1464-8431/10/294 T Robak Current Opinion in Molecular Therapeutics 2008, 10:294-309 2008-06-03 doi:10.1186/cd-912802 Current Opinion in Molecular Therapeutics 1464-8431 10 294 2008-06-03